Kraft Heinz is back in focus as one research framework trims its fair value estimate from US$27.13 to US$25.03, signaling a ...
Wondering whether Bristol-Myers Squibb at around US$57.48 is offering value right now, or if the market is signaling that it may be better to wait. The stock is up 7.5% year to date, even though it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results